INPP5D and B-cell chronic lymphocytic leukemia: Amongst CLL samples, cells derived from patients with a favorable prognosis (mutated IgVH) were more sensitive to SHIP1 inhibition than those with a poor prognosis (expressing unmutated IgVH; Supplementary Fig. 2e).